RE:RE:RE:RE:RE:RE:RE:RE:OHHHH DEAR.... TD JUST CUT TO HOLD FROM BUY Fudster, maybe CVS dropped it because it didn't sell thru their chain... immaterial to both Concordia and CVS... duhhhhh.....you can twist, turn and spin it , the retail shorts are setting up to get burned.
CVS Health confirmed this week that Nilandron®, Concordia's treatment for metastatic prostate cancer, and Dutoprol®, a treatment for high blood pressure, will be removed from CVS Health's formulary.
Concordia believes this exclusion is immaterial to its business. According to IMS prescription data, CVS did not reimburse for Nilandron® at all in the past three years and has reimbursed Dutoprol® twice in 2016.